This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07398/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07398/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07398/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07398/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07398/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07398
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n13:DB07398 n14:DB07398
dcterms:title
2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE
adms:identifier
n4:DB07398 n7:AXX n8:586370 n9:673481 n10:99443869
n5:IUPAC-Name
n6:271B408E-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4094-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4093-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4090-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4091-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4092-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B408C-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B408A-363D-11E5-9242-09173F13E4C5 n6:271B408D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B408B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B409A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B409B-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4095-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4096-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4098-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4097-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4099-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B40A0-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B40A2-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B40A3-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B409F-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B409E-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B40A1-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B408F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B409C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B409D-363D-11E5-9242-09173F13E4C5